Category Archives: Neonatal Research

Screening for early-onset neonatal sepsis in the UK. NICE or not?

Evaluating a screening procedure for a rare serious phenomenon, such as early-onset neonatal sepsis, is tricky. A perfect screening process would catch all of the cases that require treating at an early stage and would be completely specific, thus eliminating … Continue reading →

Posted in Neonatal Research | Tagged , , | 1 Comment

RSV prevention, fewer jabs for babies?

With all the hype regarding COVID-19 and a vaccine that may or may not be coming soon, we can use the story of RSV as an object lesson. Why do we give passive immunization to preterm infants against RSV rather … Continue reading →

Posted in Neonatal Research | Tagged , | 3 Comments

Why are so many mothers hypothyroid, and what should pediatricians do about it?

I don’t know if, like me, you are surprised by how often when admitting a baby, or doing an antenatal consult, mothers are taking thyroxine. It seems that there is an epidemic of hypothyroidism during pregnancy, and I am not … Continue reading →

Posted in Neonatal Research | Tagged , | 2 Comments

Treating seizures in the newborn: phenobarbitone unexpectedly not so bad!

Or perhaps “probably better than the current fashionable alternative” might be a better title. Phenobarbitone (or phenobarbital, I will call it PHE) is one of the oldest anticonvulsants out there, and because of little good data, remains the drug of … Continue reading →

Posted in Neonatal Research | Tagged , , , , | 2 Comments

Antenatal steroids : good, bad, or both?

Antenatal steroids prior to very preterm birth save lives. Antenatal steroids prior to planned late preterm delivery reduce respiratory distress and increase hypoglycaemia. Might there be other long-term effects on brain structure? There are now some animal models which suggest … Continue reading →

Posted in Neonatal Research | Tagged , , | 4 Comments

Do estimates of survival change decisions made?

Kidszun A, et al. Effect of Neonatal Outcome Estimates on Decision-Making Preferences of Mothers Facing Preterm Birth: A Randomized Clinical Trial. JAMA Pediatr. 2020. This is a short report of an interesting idea, published as a research letter. The authors … Continue reading →

Posted in Neonatal Research | Tagged | 1 Comment

Glucose screening and treatment in the newborn; what now?

This is a field that stagnated in darkness for a while, “But, soft! what light through yonder window breaks? It is the east, and science is the sun” (with apologies to Romeo). Recent research has shown that 1. In healthy … Continue reading →

Posted in Neonatal Research | Tagged | Leave a comment

Let it GLOW… Normal blood sugar profiles in newborn infants.

To stay with this recent “hot topic” of this blog; what low blood sugar threshold should be used for intervention in the neonatal period? The usual risk factors (SGA, LGA, IDM, late preterm, maternal beta-blockers) select a group of babies … Continue reading →

Posted in Neonatal Research | Tagged | 3 Comments

Not COVID-19. Who is at risk for hypoglycaemia?

In my previous post about hypoglycaemia, I made certain estimates about the proportion of well-appearing term and late preterm babies who would be considered at-risk. Karen Puopolo and her group at the Pennsylvania hospital have just published a study covering … Continue reading →

Posted in Neonatal Research | 1 Comment

Linezolid seems safe for preterms, probably

A few years ago we started having difficulty clearing Coagulase-Negative Staphylococcal (CoNS) sepsis from the blood cultures of some babies in our NICU, children with CoNS also seemed to be sicker, and to more often have thrombocytopenia. It was at … Continue reading →

Posted in Neonatal Research | Tagged , , | 1 Comment